Mera Pharmaceuticals Profit Margin

Mera Pharmaceuticals (MRPI) currently reports a profit margin of -62.02% as of October 2011. That compares with -186.18% in the prior-year period — up 66.7% year over year. That is below the Healthcare sector average of 10.58%. Use the charts on this page to explore Mera Pharmaceuticals's profit margin history and peer comparisons.

Mera Pharmaceuticals's profit margin increased from -186.18% to -62.02% — a 66.7% year-over-year increase (period ending October 2011). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Mera Pharmaceuticals's profit margin of -62.02% is lower than the Healthcare sector average of 10.58%. That is roughly 686.2% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Mera Pharmaceuticals's current -62.02% should be judged against Healthcare norms (sector average: 10.58%) and against MRPI's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -62.02%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 10.58%. From there, open related valuation or income-statement pages for Mera Pharmaceuticals, and consider following MRPI for alerts when major investors trade the stock.